308 related articles for article (PubMed ID: 25819947)
1. Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
Redecker J; Wittstock M; Benecke R; Rösche J
Epilepsy Behav; 2015 Apr; 45():176-9. PubMed ID: 25819947
[TBL] [Abstract][Full Text] [Related]
2. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
[TBL] [Abstract][Full Text] [Related]
3. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study.
Beretta S; Padovano G; Stabile A; Coppo A; Bogliun G; Avalli L; Ferrarese C
Epilepsia; 2018 Oct; 59 Suppl 2():243-248. PubMed ID: 30159874
[TBL] [Abstract][Full Text] [Related]
6. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F
Acta Neurol Scand; 2019 Apr; 139(4):369-376. PubMed ID: 30613951
[TBL] [Abstract][Full Text] [Related]
7. Perampanel in the treatment of status epilepticus: A systematic review of the literature.
Brigo F; Lattanzi S; Rohracher A; Russo E; Meletti S; Grillo E; Trinka E
Epilepsy Behav; 2018 Sep; 86():179-186. PubMed ID: 30076046
[TBL] [Abstract][Full Text] [Related]
8. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.
Rohracher A; Kalss G; Neuray C; Höfler J; Dobesberger J; Kuchukhidze G; Kreidenhuber R; Florea C; Thomschewski A; Novak HF; Pilz G; Leitinger M; Trinka E
Epilepsia; 2018 Oct; 59 Suppl 2():234-242. PubMed ID: 30043411
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effectiveness of four antiepileptic drugs in the treatment of status epilepticus according to four different efficacy criteria.
Redecker J; Wittstock M; Benecke R; Rösche J
Epilepsy Behav; 2015 Aug; 49():351-3. PubMed ID: 25960425
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
[TBL] [Abstract][Full Text] [Related]
11. Treatment and course of different subtypes of status epilepticus.
Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
Epilepsy Res; 2013 Nov; 107(1-2):156-62. PubMed ID: 24016689
[TBL] [Abstract][Full Text] [Related]
12. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of different kinds of intravenously applied antiepileptic drugs in the treatment of status epilepticus. How can it be determined?
Redecker J; Wittstock M; Rösche J
Epilepsy Behav; 2017 Jun; 71(Pt A):35-38. PubMed ID: 28460320
[TBL] [Abstract][Full Text] [Related]
14. Perampanel in achieving status epilepticus cessation: A systematic review.
Perez DQ; Espiritu AI; Jamora RDG
Epilepsy Behav; 2022 Mar; 128():108583. PubMed ID: 35151187
[TBL] [Abstract][Full Text] [Related]
15. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
[TBL] [Abstract][Full Text] [Related]
16. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
[TBL] [Abstract][Full Text] [Related]
17. Neurocritical care: status epilepticus review.
Al-Mufti F; Claassen J
Crit Care Clin; 2014 Oct; 30(4):751-64. PubMed ID: 25257739
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral perampanel in status epilepticus and acute repetitive seizures in children at a tertiary care hospital in Thailand.
Wachiropathum P; Nabangchang C; Likasitthananon N; Suwanpakdee P
Epilepsy Behav; 2021 May; 118():107964. PubMed ID: 33866126
[TBL] [Abstract][Full Text] [Related]
19. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
[TBL] [Abstract][Full Text] [Related]
20. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
Rossetti AO; Logroscino G; Bromfield EB
Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
